Akums Drugs and Pharmaceuticals Limited (BOM:544222)
750.00
-3.20 (-0.42%)
At close: Aug 21, 2026
BOM:544222 Revenue
Akums Drugs and Pharmaceuticals had revenue of 11.67B INR in the quarter ending June 30, 2026, with 13.93% growth. This brings the company's revenue in the last twelve months to 45.04B, up 9.16% year-over-year. In the fiscal year ending March 31, 2026, Akums Drugs and Pharmaceuticals had annual revenue of 43.61B with 5.84% growth.
Revenue (ttm)
45.04B
Revenue Growth
+9.16%
P/S Ratio
2.55
Revenue / Employee
6.14M
Employees
7,337
Market Cap
114.83B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 43.61B | 2.40B | 5.84% |
| Mar 31, 2025 | 41.21B | -607.25M | -1.45% |
| Mar 31, 2024 | 41.82B | 5.24B | 14.34% |
| Mar 31, 2023 | 36.57B | -180.32M | -0.49% |
| Mar 31, 2022 | 36.75B | 9.49B | 34.81% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Jubilant Pharmova | 86.08B |
| Granules India | 56.32B |
| Viyash Scientific | 35.75B |
| AstraZeneca Pharma India | 24.32B |
| Caplin Point Laboratories | 22.87B |
| FDC Limited | 21.90B |
| Morepen Laboratories | 19.51B |
| Sanofi India | 18.05B |
Akums Drugs and Pharmaceuticals News
- 12 days ago - Akums Drugs and Pharmaceuticals Transcript: Q1 26/27 - Transcripts
- 12 days ago - Akums Drugs and Pharmaceuticals Quarterly report: Q1 2027 - Filings
- 12 days ago - Akums Drugs and Pharmaceuticals Slides: Q1 2027 - Filings
- 2 months ago - Akums Drugs and Pharmaceuticals announces 22nd AGM and annual report availability - Business Upturn
- 2 months ago - Akums Drugs and Pharmaceuticals reports 79.95% turnover from pharma manufacturing - Business Upturn
- 2 months ago - Akums announces 22nd AGM and dividend details in newspaper advertisement - Business Upturn
- 3 months ago - Akums Drugs and Pharmaceuticals Transcript: Q4 25/26 - Transcripts
- 3 months ago - Akums Drugs and Pharmaceuticals Quarterly report: Q4 2026 - Filings